SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-17-003095
Filing Date
2017-03-31
Accepted
2017-03-31 17:03:22
Documents
84
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K t1700098-10k.htm 10-K 1258172
2 EXHIBIT 10.14 t1700098_ex10-14.htm EX-10.14 4391
3 EXHIBIT 10.15 t1700098_ex10-15.htm EX-10.15 4376
4 EXHIBIT 23.1 t1700098_ex23-1.htm EX-23.1 1954
5 EXHIBIT 31.1 t1700098_ex31-1.htm EX-31.1 9397
6 EXHIBIT 31.2 t1700098_ex31-2.htm EX-31.2 9428
7 EXHIBIT 32.1 t1700098_ex32-1.htm EX-32.1 3893
8 EXHIBIT 32.2 t1700098_ex32-2.htm EX-32.2 3946
  Complete submission text file 0001571049-17-003095.txt   5597406

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE cycc-20161231.xml EX-101.INS 1029378
10 XBRL SCHEMA FILE cycc-20161231.xsd EX-101.SCH 52482
11 XBRL CALCULATION FILE cycc-20161231_cal.xml EX-101.CAL 50823
12 XBRL DEFINITION FILE cycc-20161231_def.xml EX-101.DEF 170416
13 XBRL LABEL FILE cycc-20161231_lab.xml EX-101.LAB 473753
14 XBRL PRESENTATION FILE cycc-20161231_pre.xml EX-101.PRE 323610
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 17731179
SIC: 2834 Pharmaceutical Preparations